{
  "catalogId": "a8336565-c1fa-434c-9317-fb7b921ba2f7",
  "name": "ROTATEQ",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "136 76 31569 00",
  "treatmentDescriptions": "RotaTeq  is indicated for the prevention of rotavirus gastroenteritis in infants and children caused by types G1, G2, G3, G4, and G9 when administered as a 3-dose series to infants between the ages of 6 to 32 weeks. The first dose of RotaTeq should be administered between 6 and 12 weeks of age.",
  "termsOfIssue": "Prescription required",
  "form": "oral solution",
  "route": "per os",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "ROTAVIRUS P1A(8) REASSORTANT 1.15 X10^6 IU/ML, ROTAVIRUS G2 REASSORTANT 1.4 X10^6 IU/ML, ROTAVIRUS G4 REASSORTANT 1.0 X10^6   IU/ML, ROTAVIRUS G3 REASSORTANT 1.1 X10^6 IU/ML, ROTAVIRUS G1 REASSORTANT 1.1 X10^6 IU/ML",
  "codes": {},
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "ROTATEQ VACCINE",
      "manufacturer": {
        "name": "",
        "countryOfOrigin": "IL"
      },
      "strength": [],
      "quantity": {
        "value": 1.0,
        "unit": "units"
      },
      "packagingDescription": "CONTAINER UNIT DOSE PLASTIC",
      "shelfLife": "24",
      "storageConditions": "",
      "codes": {
        "moh": "6033",
        "yarpa": "72706",
        "pharmasoft": "18374"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": "",
        "retailMargin": "",
        "maxRetailPrice": "",
        "maxPriceWithVAT": ""
      },
      "formulation": ""
    }
  ],
  "metadata": {
    "version": "1.5",
    "lastUpdated": "2025-08-01T18:03:51.749381"
  }
}